CLChen-Fuh Lam

Chen-Fuh Lam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chen-Fuh Lam has a total of 122 co-authors. Here are the top co-authors by number of shared publications:

  • Chien-Chi Huang

    Department of Medical Research, E-Da Hospital, I-Shou University, Kaohsiung, 824, Taiwan

    10 shared publications
  • Jun-Neng Roan

    Division of Cardiovascular Surgery, Department of Surgery, National Cheng Kung University Hospital and College of Medicine, Tainan, Taiwan

    9 shared publications
  • Shih-Yuan Fang

    Department of Anesthesiology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

    7 shared publications
  • Tzu-Ting Cheng

    Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung, 824, Taiwan

    6 shared publications
  • Ming-Wei Lin

    Department of Anesthesiology, Chi Mei Medical Center, Tainan 710, Taiwan

    5 shared publications
  • Yu-Chuan Tsai

    Department of Anesthesiology, E-Da Hospital and E-Da Cancer Hospital, Kaohsiung, Taiwan

    5 shared publications

Latest Publications

  • Open Access

    Frailty and clinical risk factors for symptomatic spinal epidural hematoma requiring urgent surgical evacuation after spine surgery – a single-center retrospective case–control study

    by Chih-Chun Chen, Shu-Jiuan Chen, Ya-Ling Mai, Yi-Chieh Chiang, Chen-Fuh Lam, Jin-Cherng Chen

    Objective: This study aimed to identify the relationship between patient frailty levels, other perioperative risk factors, and the development of postoperative spinal epidural hematoma (PSEH) in the modern era, during which numerous innovations in surgical techniques and intraoperative imaging systems have been developed. Design: A retrospective matched case–control study conducted at a tertiary teaching hospital. Settings: Clinical data were retrieved from the electronic database from 1 January 2023 to 31 May 2025. Patients: Patients who developed symptomatic PSEH after spine surgery and required urgent surgical evacuation were included, and those did not require postoperative re-intervention were randomly selected (ratio of 1:5) from the same database and served as matched controls. Measurements: Patient-related factors, including preoperative Clinical Frailty Scale (CFS), as well as surgical and anesthesia-related factors, were compared between the symptomatic PSEH reintervention group and the matched control group. A conditional logistic regression model was used for multivariate analysis. Main results: A total of 13 patients developed symptomatic PSEH during the study period, and 64 patients were matched from a total of 2,095 spine surgeries that did not require re-intervention. Symptomatic PSEH patients were associated with higher preoperative CFS (adjusted odds ratio (AOR) 2.75, 95% confidence interval (CI) 1.08–7.06; P = 0.002), and there were more cases who received revision procedures (AOR 8.36, 95% CI 1.26–55.64, P = 0.028). Patients who experienced intraoperative hypothermia (< 36 °C) were also associated with a higher risk of developing symptomatic PSEH. Urgent surgical evacuation of epidural bleeding extended hospital stays (mean difference in days 8.20, 95% CI 3.13–13.26; P = 0.002). Conclusion: The overall incidence rate of symptomatic PSEH requiring surgical intervention was 0.62%. Patients with higher CFS and those undertaking revision spine surgery are associated with increased risks of major symptomatic PSEH. Perioperative care, including maintaining normal body temperature, may help reduce the incidence of symptomatic PSEH.

  • Open Access

    TRANSPLANTATION OF VIABLE ALLOGENEIC MITOCHONDRIA PROTECTS KIDNEY FUNCTION IN A MOUSE MODEL OF HEMORRHAGIC SHOCK AND RHABDOMYOLYSIS-INDUCED ACUTE RENAL INJURY

    by Yu-Li Pang, Shi-Yuan Fang, Chien-Chi Huang, Ming-Wei Lin, Jun-Neng Roan, Kuen-Jer Tsai, Chen-Fuh Lam

    Background and Aims: Acute kidney injury (AKI) is independently associated with high mortality after major trauma. Because mitochondrial dysfunction in renal tubular cells is a critical early subcellular change in AKI, this study proposed that administration of freshly harvested viable mitochondria could ameliorate renal tubular injury in a mouse model of two-hit rhabdomyolysis-related AKI. Methods: Mice were subjected to acute hemorrhagic shock and rhabdomyolysis through blood withdrawal and intramuscular glycerol injection. Mitochondria (100 μg) were freshly isolated from the soleus muscles of naïve mice. Mitochondria or placebo solution was randomly delivered into arterial catheter 1 h after the induction of AKI. The mice were euthanized 36 h later, and blood samples and kidneys were collected for analysis. Results: IVIS imaging confirmed increased expression of fluorescence-labeled allogeneic mitochondrial accumulation in AKI kidneys. Mitochondrial transplantation significantly decreased the elevated serum levels of urea nitrogen, creatinine and potassium. The protein expression of endogenous antioxidant molecules (Nrf-2, heme oxygenase-1 and superoxide dismutases) was significantly increased. The BAX-to-Bcl-2 ratio and expression of cleaved caspace-3 were also reduced in the mitochondrial-transplanted animals, indicating the attenuation of mitochondrial-mediated apoptosis in the kidney tissues of AKI mice. Histopathological examination confirmed that degrees of renal tubular injury were improved following mitochondrial transplantation. Conclusions: Transplantation of freshly isolated mitochondria augments endogenous antioxidant capacity and ameliorates mitochondrial apoptosis in the injured kidney tissues after hemorrhagic shock and rhabdomyolysis-induced AKI. Allogeneic mitochondrial transplantation could be a potential and feasible therapeutic option for prevention and management of AKI secondary to major trauma.


  • Open Access

    Radiographical presentations of inadvertent subdural placement of an epidural catheter for successful labor analgesia: A case report

    by Wei-An Chen, Ming-Cheng Wu, Chen-Fuh Lam, Chang-Hsien Ou

    Rationale: Lumbar epidural analgesia is the gold standard for labor pain control. However, misplacement of epidural catheters into the subdural space may inadvertently happen. Unrecognized subdural administration of local anesthetics could result in serious consequences, including high spinal and brainstem blocks. This case report describes a case where subdural epidural catheter placement was recognized early but labor pain was adequately managed by dosage titration of subdural analgesia. Patient concerns: This case report describes a 29-year-old primiparous pregnant woman who was admitted to our obstetric unit for labor induction at the gestational age of 38 weeks. An epidural catheter was inserted via the L2-3 intervertebral space using the standard loss of resistance to air technique. Diagnoses: The parturient experienced weakness in the lower extremities and numbness in the upper extremities within 15 minutes after administration of 5 mL of 2% v/v lidocaine as a loading dose and systolic blood pressure also dropped by 25%. Interventions: The dose regimen (a mixture of 0.1% ropivacaine and 4 μg/mL fentanyl) for patient-controlled analgesia was given with bolus doses of 0.1 mL per demand and lockout intervals of 20 minutes. The analgesic effects were adequately maintained below the T8 dermatome for more than 12 hours without hypotensive episodes or obvious signs of neurological deficits. Computed tomographic myelography was performed by instillation of a nonionic iodinated contrast medium via the epidural catheter on postpartum day 2 for imaging confirmation of catheter placement in the extradural space. Lessons: Early recognition that epidural catheters for neuraxial analgesia have been inserted into the subdural space is important for the prevention of high spinal blocks. Subdural analgesia could still be achieved by careful clinical assessment and titration of low analgesic doses. This report also presents important and clear serial computed tomographic images of catheter placement in the thoracic-lumbar subdural spaces and the extent of volume spread in the subdural space following administration of contrast medium.


  • Open Access

    Efficacy and safety of an extended-release sebacoyl dinalbuphine ester for laparoscopic cholecystectomy: A randomized controlled trial

    by Ying-En Lee, Chen-Yu Fu, Yow-Ling Shiue, Chu-Yun Lu, Chung-Yen Chen, Jian-Han Chen, Jen-Lung Chen, Chen-Fuh Lam

    Background: A long-acting κreceptor agonist parenteral analgesic may theoretically improve acute pain and reduce incidence of chronic postsurgical pain (CPSP) after laparoscopic cholecystectomy with minimal drug-related side effects of the traditional μreceptor opioids. Methods: Eighty adult patients undergoing elective laparoscopic cholecystectomy were randomly assigned to receive single intramuscular injection of an extended-release sebacoyl dinalbuphine ester (SDE, Naldebain 150 mg; n = 40) or placebo ( n = 40) after anesthesia induction. Standard multimodal analgesia (MMA) was administered for postoperative pain control. The primary endpoint was pain intensity within 7 days after surgery. The secondary endpoints were incidence CPSP at 3 months and adverse reactions up to 7 days after surgery. Results: The highest visual analogue scale (VAS) and area under the curve of VAS 0 to 48 hours after operation were not different between the two groups and a similar proportion of patients requested rescue parenteral analgesics. Average pain intensities were also not different at 72 hours and 7 days after surgery. Incidence of CPSP was 22.5% and 13.1% in patients who received placebo and SDE treatment, respectively ( P = .379). Significantly higher incidence of drug-related adverse events, including dizziness, nausea and injection site reactions, were recorded in the SDE group. Conclusion: A single dose of extended-release analgesic SDE given intraoperatively did not provide sufficient add-on effect for acute and chronic pain management after laparoscopic cholecystectomies in patients who received standard postoperative MMA. Intramuscular injection of 150 mg SDE in patients with average body mass causes adverse events that could have been overlooked. More clinical studies are warranted to determine the target populations who may benefit from SDE injections for improvement of acute and chronic postsurgical pain management.


  • Open Access

    Dual phenotypic characteristics of P-selectin in a mouse model of hemorrhagic shock and hepatectomy

    by Jen-Lung Chen, Tzu-Ting Cheng, Chien-Chi Huang, Hsin-Hou Chang, Chen-Fuh Lam


  • Open Access

    Post-extubation use of high-flow nasal oxygenation induces upper airway leak and intrathoracic sepsis after successful Bentall procedure: A case report

    by Yu-Yang Liao, Hsuan-Yin Wu, Chen-Fuh Lam, Yi-Ming Wang

    Rationale: In recent few years, high-flow nasal oxygenation (HFNO) has been widely used for management of acute hypoxemic respiratory failure and during postextubation periods, including after endotracheal intubation general anesthesia (ETGA). However, HFNO generates positive pressure in the injured airway following removal of endotracheal tube may cause airway leaks. This is the first case report of severe airway leak syndrome following postextubation use of HFNO in surgical patients. Patient concerns: This case report describes a 75-year-old female with critical aortic stenosis who underwent an emergency Bentall procedure. HFNO (flow rate of 45 L/min) was applied after weaning from mechanical ventilation and removal of the endotracheal tube. Diagnoses: At 6 hours after HFNO application, subcutaneous emphysema in the neck bilaterally and face was noted, and the emphysema extended into the supraclavicular regions. Interventions: The HFNO cannula was removed soon after and the patient was re-intubated with an endotracheal tube the following day due to progressive respiratory insufficiency. Unfortunately, the patient general condition deteriorated, as the subcutaneous air collections progressed into deep tissue infections of the neck, mediastinal abscesses, and left-sided empyema. Patient received surgical interventions repeatedly to drain the mediastinal abscess and empiric antimicrobial therapy was given. Outcomes: The patient passed away about 2 months later due to uncontrollable sepsis. Lessons: Air leaks in the upper airway can occur during the use of post-extubation HFNO use, and the resulting subcutaneous emphysema can progress to severe intrathoracic infections in surgical patients who have a sternotomy wound. Therefore, HFNO-induced subcutaneous emphysema should be treated more aggressively in open thoracic or sternotomy surgeries to prevent the development of intrathoracic sepsis.


  • Intraoperative Enteral Nutrition Feeding in Free‐Flap Healing after Reconstruction Surgery for Head and Neck Cancers

    by Tzer‐Zen Hwang, Yi‐Ming Wang, Seng‐Feng Jeng, Yi‐Chen Lee, Tzu‐Shan Chen, Shin‐Ying Su, Chien‐Chi Huang, Chen‐Fuh Lam

    Objective: To investigate the beneficial outcomes of intraoperative enteral feeding in free‐flap regeneration after extended head and neck cancer resection and flap reconstruction surgery.Study Design: A pilot randomized, double‐blind, placebo‐controlled clinical trial.Setting: Single tertiary care center.Methods: Patients with advanced head and neck cancers requiring radical tumor resections and free‐flap reconstruction were randomly assigned to receive intraoperative enteral nutrition feeding (100 kcal/100 mL at 10‐20 mL/h) via a nasogastric tube during free‐flap reconstruction (n = 28) or continue fasting (n = 28). The primary outcome was impaired free‐flap regeneration that required surgical reintervention within 90 days after the operation. Participants were enrolled between April 2020 and January 2022; the 90‐day follow‐up ended in April 2022.Results: The incidence of total or partial flap failure was similar between the 2 groups (14.2% or n = 4 in each group), but the rate of wound dehiscence or edge necrosis was significantly reduced in the feeding group (n = 6 vs 0 for fasting vs feeding; absolute risk reduction, 25.0% [95% confidence interval, 6.9‐43.0]%; p = 0.022). Hospital stay length was shorter (p = 0.042) and hand grip strength was better preserved (p = 0.025) in the feeding group. Plasma concentrations of interleukin (IL)‐6 and IL‐8 after the operation increased significantly more in the fasting group. Perioperative adverse events did not differ between the 2 groups.Conclusion: Perioperative enteral feeding is a simple, safe, and effective approach to improve perioperative systemic catabolism and proinflammatory reactions, thereby enhancing early wound regeneration after major operations.


  • Efficacy and Safety of Parenteral Injection of an Extended Release κ-receptor Opioid Sebacoyl Dinalbuphine Ester for Acute and Chronic Pain After Laparoscopic Bariatric Surgery: a Randomized, Placebo-Controlled, Double-Blind Trial

    by Ying-En Lee, Shao-Ye Wang, Jian-Han Chen, Chung-Yen Chen, Yow-Ling Shiue, Tien-Chou Soong, Chen-Fuh Lam

    Purpose μ-receptor opioids are associated with unwanted gastrointestinal side effects and respiratory depression. A long-acting non-μ-receptor parenteral opioid is not currently available for management of acute and chronic postsurgical pain (CPSP). This double-blind clinical trial tested an extended-release κ-receptor agonist, sebacoyl dinalbuphine ester (SDE, Naldebain®) for management of surgical pain after laparoscopic bariatric surgery. Materials and Methods Patients were randomly assigned to receive a single intramuscular injection of SDE (150 mg, n = 30) or vehicle solution (n = 30) at > 12 h before surgery. All patients received standard perioperative multimodal analgesia (MMA). The primary endpoint was the pain intensity in the beginning 7 days after operation. The secondary endpoints were adverse reactions up to 7 days and incidence of CPSP at 3 months after surgery. Results Compared with placebos, the area under curves of visual analog scale (VAS) for 0–48 h after operation were significantly reduced in SDE group (143.3 ± 65.4 and 105.9 ± 36.3, P = 0.025). There were significantly fewer patients in the SDE group who had moderate-to-severe pain (VAS ≥ 4) (16.7% vs 50%; P = 0.012) at postoperative 48 h. Pain intensities were similar between the two groups at 72 h and 7 days postoperatively. The incidence of CPSP at 3 months was not different. SDE did not increase drug-related systemic adverse events. Conclusion In addition to the standard perioperative MMA, a single-dose injection of long-acting κ-receptor agonist SDE provides significantly better pain management for 48 h following laparoscopic bariatric surgery. A long-acting κ-receptor agonist opioid could improve in-hospital pain management and potentiate early discharge after operation without increasing drug-related systemic complications. Graphical Abstract


  • Open Access

    Viable Allogeneic Mitochondria Transplantation Improves Gas Exchange and Alveolar-Capillary Permeability in Rats with Endotoxin-Induced Acute Lung Injuries

    by Yu-Li Pang, Shi-Yuan Fang, Tzu-Ting Cheng, Chien-Chi Huang, Ming-Wei Lin, Chen-Fuh Lam, Kuen-Bao Chen

    Background: Acute lung injuries (ALI) cause disruption of the alveolar-capillary barrier and is the leading cause of death in critically ill patients. This study tested the hypothesis that the administration of freshly isolated viable allogeneic mitochondria can prevent alveolar-capillary barrier injuries at the endothelial level, as mitochondrial dysfunction of the pulmonary endothelium is a critical aspect of ALI progression.